An analgesic to bridge the gap between Narcotics and NSAIDs: opiorphin
Authors:
Open Access
- 22 June 2018
- journal article
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 7 (7) , 1432-1436
Abstract
Pain management is an all-time challenge in dentistry. Discontent to pain management is a concern among patients and professionals. Unrelieved pain affects physical and mental well-being contributing to delayed recovery, psychological distress and anxiety. Studies have revealed that chronic pain interferes with normal daily chores of the individual like exercise, sleep, social life and lifestyle. At one end of pain management spectrum are Non-steroidal anti-inflammatory drugs (NSAIDs) while at the other end are the opioids. These drugs are not without constituent side effects. The quest is for new analgesics with potent and long term analgesia with minimal or no side effects. An analgesic that is intermediate in this spectrum is the need of the hour. Opiorphin is an endogenous peptide isolated from human saliva. Opiorphin produces analgesia, by inhibiting enkephalin (ENK) metabolizing enzymes, thus increasing the half-life of circulating ENKs. Apart from being a potent analgesic it can also be a potential biomarker for various systemic and psychosocial disorders. This review focuses on the pharmacological effects of opiorphin and its potential role as a biomarker in various disease conditions.Keywords
This publication has 14 references indexed in Scilit:
- Opiorphin in burning mouth syndrome patients: a case-control studyClinical Oral Investigations, 2016
- Opiorphin levels in fluids of burning mouth syndrome patients: a case-control studyClinical Oral Investigations, 2016
- STR-324, a Stable Analog of Opiorphin, Causes Analgesia in Postoperative Pain by Activating Endogenous Opioid Receptor–dependent PathwaysAnesthesiology, 2016
- Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized ratsEuropean Journal of Pharmacology, 2015
- Structure–Activity Relationship Study of Opiorphin, a Human Dual Ectopeptidase Inhibitor with Antinociceptive PropertiesJournal of Medicinal Chemistry, 2012
- Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of opiorphin in human salivaJournal of Chromatography B, 2011
- The antidepressant-like effect of human opiorphin via opioid-dependent pathways in miceNeuroscience Letters, 2011
- Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in micePeptides, 2009
- RB101‐mediated Protection of Endogenous Opioids: Potential Therapeutic Utility?CNS Drug Reviews, 2007
- Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathwaysProceedings of the National Academy of Sciences, 2006